BCL2 and B-cell chronic lymphocytic leukemia: However, in drug combination experiments with fludarabine or the BCL2 inhibitor ABT-737, metformin enabled lower doses of each agent studied to decrease the apoptotic threshold and potentiate CLL cell death [54].